Skip to main content
Top
Published in: Journal of Community Health 4/2012

01-08-2012 | Review

Opportunities for Cost Reduction of Medical Care: Part 3

Authors: Monte Malach, William J. Baumol

Published in: Journal of Community Health | Issue 4/2012

Login to get access

Abstract

The level of health care spending in the United States and other developed nations is rising at a disturbingly rapid rate. However, in the United States, these increases are not justified by superior performance. Rather, most other wealthy countries’ inhabitants live longer and suffer from fewer medical problems than the average American. This paper demonstrates the continued abundance of opportunities for substantially reducing health care costs without decreasing the quality of care. In particular, it emphasizes the need to reduce the practice of defensive medicine and to enlarge the cadre of non-specialist physicians who educate future doctors. Such cost-saving opportunities are not rare phenomena but are widely available and offer the United States opportunities to move toward the markedly lower cost levels that have been achieved in other countries.
Footnotes
1
In the interest of thoroughness, some of the examples cited in our previous papers [2, 3] are repeated here.
 
Literature
1.
go back to reference Baumol, W. J. (1993). Social wants and dismal science: The curious case of the climbing costs of health care and teaching. Proceedings of the American Philosophical Society, 134, 612–637. Baumol, W. J. (1993). Social wants and dismal science: The curious case of the climbing costs of health care and teaching. Proceedings of the American Philosophical Society, 134, 612–637.
2.
go back to reference Malach, M., & Baumol, W. J. (2009). Opportunities for the cost reduction of medical care. Journal of Community Heath, 34, 255–261.CrossRef Malach, M., & Baumol, W. J. (2009). Opportunities for the cost reduction of medical care. Journal of Community Heath, 34, 255–261.CrossRef
3.
go back to reference Malach, M., & Baumol, W. J. (2010). Further opportunities for cost reduction of medical care. Journal of Community Health, 35, 561–571.PubMedCrossRef Malach, M., & Baumol, W. J. (2010). Further opportunities for cost reduction of medical care. Journal of Community Health, 35, 561–571.PubMedCrossRef
4.
go back to reference Government Accounting Office. (2003, August). Medical malpractice. Government Accounting Office. (2003, August). Medical malpractice.
5.
go back to reference Parekh, A. K., & Barton, M. B. (2010). The challenge of multiple co-morbidity for the U.S. health care system. Journal of the American Medical Association, 303, 1303–1304.PubMedCrossRef Parekh, A. K., & Barton, M. B. (2010). The challenge of multiple co-morbidity for the U.S. health care system. Journal of the American Medical Association, 303, 1303–1304.PubMedCrossRef
6.
go back to reference Braunwald, E. (2009). Cardiology as a profession in 2020 and beyond. ACCEL. American College of Cardiology, 41–11, Disc 2, Track 1. Braunwald, E. (2009). Cardiology as a profession in 2020 and beyond. ACCEL. American College of Cardiology, 41–11, Disc 2, Track 1.
7.
go back to reference Cooke, M. (2010). Cost consciousness in patient care: What is medical education’s responsibility? New England Journal of Medicine, 362, 1253–1255. Cooke, M. (2010). Cost consciousness in patient care: What is medical education’s responsibility? New England Journal of Medicine, 362, 1253–1255.
8.
go back to reference Miller, F. G., & Jaffe, S. (2011). Equipoise and the dilemma of randomized clinical trials. New England Journal of Medicine, 364, 476–479.PubMedCrossRef Miller, F. G., & Jaffe, S. (2011). Equipoise and the dilemma of randomized clinical trials. New England Journal of Medicine, 364, 476–479.PubMedCrossRef
9.
go back to reference Centers for Disease Control and Prevention. (2011). Ten great public health achievements in the United States 2001–2010. Morbidity and mortality weekly report. Journal of the American Medical Association, 306, 36–38. Centers for Disease Control and Prevention. (2011). Ten great public health achievements in the United States 2001–2010. Morbidity and mortality weekly report. Journal of the American Medical Association, 306, 36–38.
10.
go back to reference Malach, M., & Imperato, P. (2006). Acute myocardial infarction and acute coronary syndrome: Then and now 1950–2005. Preventive Cardiology, 9, 225–234.CrossRef Malach, M., & Imperato, P. (2006). Acute myocardial infarction and acute coronary syndrome: Then and now 1950–2005. Preventive Cardiology, 9, 225–234.CrossRef
11.
go back to reference Ford, E., et al. (2007). Exploring the decrease in U.S. deaths from coronary disease 1980–2000. New England Journal of Medicine, 356, 2388–2398.PubMedCrossRef Ford, E., et al. (2007). Exploring the decrease in U.S. deaths from coronary disease 1980–2000. New England Journal of Medicine, 356, 2388–2398.PubMedCrossRef
12.
go back to reference Boden, W., et al. (2009). Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (The COURAGE Trial). American Journal of Cardiology, 104, 1–4.PubMedCrossRef Boden, W., et al. (2009). Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (The COURAGE Trial). American Journal of Cardiology, 104, 1–4.PubMedCrossRef
13.
go back to reference Patel, M. R., Peterson, E. D., Dai, D., et al. (2010). Low diagnostic yield of elective coronary angiography. New England Journal of Medicine, 363, 498. Patel, M. R., Peterson, E. D., Dai, D., et al. (2010). Low diagnostic yield of elective coronary angiography. New England Journal of Medicine, 363, 498.
14.
go back to reference Dammon, P., et al. (2010). No long-term benefit to early invasive strategy in ICTUS trial. Journal of the American College of Cardiology, 56, 858–864.CrossRef Dammon, P., et al. (2010). No long-term benefit to early invasive strategy in ICTUS trial. Journal of the American College of Cardiology, 56, 858–864.CrossRef
15.
go back to reference Tarkelson, C. J., et al. (2011). Health care system delay and health failure in patients with ST-segment elevation myocardial infarction treated with PCI: Follow-up population-based medical registry data. Annals of Internal Medicine, 155, 361–367. Tarkelson, C. J., et al. (2011). Health care system delay and health failure in patients with ST-segment elevation myocardial infarction treated with PCI: Follow-up population-based medical registry data. Annals of Internal Medicine, 155, 361–367.
16.
go back to reference Vlaar, P. J., Mahmoud, K., et al. (2011). Culprit vessel only versus multi-vessel and staged percutaneous coronary intervention for multi-vessel disease in patients presenting with ST-segment elevation myocardial infarction: A pairwise and network meta-analysis. Journal of the American College of Cardiology, 58, 692–703.PubMedCrossRef Vlaar, P. J., Mahmoud, K., et al. (2011). Culprit vessel only versus multi-vessel and staged percutaneous coronary intervention for multi-vessel disease in patients presenting with ST-segment elevation myocardial infarction: A pairwise and network meta-analysis. Journal of the American College of Cardiology, 58, 692–703.PubMedCrossRef
17.
go back to reference Chan, P. S., et al. (2011). Appropriateness of percutaneous coronary intervention. Journal of the American Medical Association, 306, 53–61.PubMedCrossRef Chan, P. S., et al. (2011). Appropriateness of percutaneous coronary intervention. Journal of the American Medical Association, 306, 53–61.PubMedCrossRef
18.
go back to reference Mega, J. L. (2011). A new era for anticoagulation in atrial fibrillation. New England Journal of Medicine, 365, 1052–1053.PubMedCrossRef Mega, J. L. (2011). A new era for anticoagulation in atrial fibrillation. New England Journal of Medicine, 365, 1052–1053.PubMedCrossRef
19.
go back to reference Feldman, T., et al. (2011). Percutaneous repair or surgery for mitral regurgitation. New England Journal of Medicine, 364, 1395–1406.PubMedCrossRef Feldman, T., et al. (2011). Percutaneous repair or surgery for mitral regurgitation. New England Journal of Medicine, 364, 1395–1406.PubMedCrossRef
20.
go back to reference Smith, C. R., et al. (2011). Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine, 364, 2187–2198.PubMedCrossRef Smith, C. R., et al. (2011). Transcatheter versus surgical aortic-valve replacement in high-risk patients. New England Journal of Medicine, 364, 2187–2198.PubMedCrossRef
21.
go back to reference Greenberg, R. K. et al. (2006). Beyond the aortic bifurcation: Branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. Journal of Vascular Surgery, 43, 879–886; discussion 886-887. Greenberg, R. K. et al. (2006). Beyond the aortic bifurcation: Branched endovascular grafts for thoracoabdominal and aortoiliac aneurysms. Journal of Vascular Surgery, 43, 879–886; discussion 886-887.
22.
go back to reference Plaisance, B. R., et al. (2011). Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI registry. Journal of the American College of Cardiology: Cardiovascular Interventions, 4, 694–701. Plaisance, B. R., et al. (2011). Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI registry. Journal of the American College of Cardiology: Cardiovascular Interventions, 4, 694–701.
23.
go back to reference White, C. J., et al. (2011). Stroke intervention: Catheter-based therapy for acute ischemic stroke. Journal of the American College of Cardiology, 58, 101–116.PubMedCrossRef White, C. J., et al. (2011). Stroke intervention: Catheter-based therapy for acute ischemic stroke. Journal of the American College of Cardiology, 58, 101–116.PubMedCrossRef
24.
go back to reference Chimowitz, M. I., et al. (2011). Stenting vessels as aggressive medical therapy for intracranial arterial stenoses. New England Journal of Medicine, 365, 993–1003.PubMedCrossRef Chimowitz, M. I., et al. (2011). Stenting vessels as aggressive medical therapy for intracranial arterial stenoses. New England Journal of Medicine, 365, 993–1003.PubMedCrossRef
25.
go back to reference O’Connor, C. M., et al. (2011). Effect of nesiritide in patients with acute decompensated heart failure. New England Journal of Medicine, 365, 32–43.PubMedCrossRef O’Connor, C. M., et al. (2011). Effect of nesiritide in patients with acute decompensated heart failure. New England Journal of Medicine, 365, 32–43.PubMedCrossRef
26.
go back to reference Al-Khatib, S. M., et al. (2011). Non-evidence-based ICD implantations in the United States. Journal of the American Medical Association, 305, 43–49.PubMedCrossRef Al-Khatib, S. M., et al. (2011). Non-evidence-based ICD implantations in the United States. Journal of the American Medical Association, 305, 43–49.PubMedCrossRef
29.
go back to reference Sidhu, R., et al. (2008). Guidelines on small bowell enteroscopy and capsule endoscopy in adults. Gut, 57, 125–136.PubMedCrossRef Sidhu, R., et al. (2008). Guidelines on small bowell enteroscopy and capsule endoscopy in adults. Gut, 57, 125–136.PubMedCrossRef
30.
go back to reference Weinberg, D. S. (2011). Colonoscopy: What does it take to get it ‘right?’ Annals of Internal Medicine, 154, 68–69. Weinberg, D. S. (2011). Colonoscopy: What does it take to get it ‘right?’ Annals of Internal Medicine, 154, 68–69.
31.
go back to reference Flossmann, E., et al. (2007). Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. The Lancet, 369, 1603–1613.CrossRef Flossmann, E., et al. (2007). Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. The Lancet, 369, 1603–1613.CrossRef
32.
go back to reference Larsson, S. C., et al. (2010). Vitamin B6 and risk of colorectal cancer: A meta-analysis of prospective studies. Journal of the American Medical Association, 303, 1077–1083.PubMedCrossRef Larsson, S. C., et al. (2010). Vitamin B6 and risk of colorectal cancer: A meta-analysis of prospective studies. Journal of the American Medical Association, 303, 1077–1083.PubMedCrossRef
33.
go back to reference El Sarag, H. B. (2011). Hepatocelular carcinoma. New England Journal of Medicine, 365, 1134–1143. El Sarag, H. B. (2011). Hepatocelular carcinoma. New England Journal of Medicine, 365, 1134–1143.
34.
go back to reference Pimentel, M., et al. (2011). Rifaximin therapy for patients with irritable bowel syndrome without constipation. New England Journal of Medicine, 364, 22–32.PubMedCrossRef Pimentel, M., et al. (2011). Rifaximin therapy for patients with irritable bowel syndrome without constipation. New England Journal of Medicine, 364, 22–32.PubMedCrossRef
35.
go back to reference Johannesson, E., et al. (2011). Physical activity improves symptoms in irritable bowel syndrome: A randomized controlled trial. American Journal of Gastroenterology, 106, 915–922.PubMedCrossRef Johannesson, E., et al. (2011). Physical activity improves symptoms in irritable bowel syndrome: A randomized controlled trial. American Journal of Gastroenterology, 106, 915–922.PubMedCrossRef
36.
go back to reference Arijs, I., et al. (2010). Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease. Inflammatory Bowel Diseases, 16, 2090–2098.PubMedCrossRef Arijs, I., et al. (2010). Predictive value of epithelial gene expression profiles for response to infliximab in Crohn’s disease. Inflammatory Bowel Diseases, 16, 2090–2098.PubMedCrossRef
37.
go back to reference Bass, N. M., et al. (2010). Rifaximin treatment in hepatic encephalopathy. New England Journal of Medicine, 362, 1071–1081.PubMedCrossRef Bass, N. M., et al. (2010). Rifaximin treatment in hepatic encephalopathy. New England Journal of Medicine, 362, 1071–1081.PubMedCrossRef
39.
go back to reference Finks, J. F., et al. (2011). Trends in hospital volume and operative mortality for high-risk surgery. New England Journal of Medicine, 364, 2128–2137.PubMedCrossRef Finks, J. F., et al. (2011). Trends in hospital volume and operative mortality for high-risk surgery. New England Journal of Medicine, 364, 2128–2137.PubMedCrossRef
40.
go back to reference Deijo, R. A., et al. (2010). Surgery for lumbar spinal stenosis in older adults. Journal of the American Medical Association, 303, 1259–1265.CrossRef Deijo, R. A., et al. (2010). Surgery for lumbar spinal stenosis in older adults. Journal of the American Medical Association, 303, 1259–1265.CrossRef
41.
go back to reference Meier, B. (2011). Challenges rise as metallic hips fail at fast rate. New York Times, A1, A3. Meier, B. (2011). Challenges rise as metallic hips fail at fast rate. New York Times, A1, A3.
42.
go back to reference Walker, E. P. (2011). Fee hikes no cause for slow device reviews. Med Page Today. Walker, E. P. (2011). Fee hikes no cause for slow device reviews. Med Page Today.
43.
go back to reference Eisenberg, A. (2010). Replacement bones grown to order in the lab. New York Times, B5. Eisenberg, A. (2010). Replacement bones grown to order in the lab. New York Times, B5.
44.
go back to reference Bäcker, M., et al. (2011). Effectiveness of leech therapy in chronic lateral epicondylitis: A randomized controlled trial. Clinical Journal of Pain, 27, 442–447.PubMedCrossRef Bäcker, M., et al. (2011). Effectiveness of leech therapy in chronic lateral epicondylitis: A randomized controlled trial. Clinical Journal of Pain, 27, 442–447.PubMedCrossRef
45.
go back to reference Brawley, O. W., et al. (2010). Effect of duasteride on the risk of prostate cancer. New England Journal of Medicine, 362, 1235–1236.CrossRef Brawley, O. W., et al. (2010). Effect of duasteride on the risk of prostate cancer. New England Journal of Medicine, 362, 1235–1236.CrossRef
46.
go back to reference Harris, G. (2011). U.S. panel says no to prostate tests for healthy men. New York Times, A1, A3. Harris, G. (2011). U.S. panel says no to prostate tests for healthy men. New York Times, A1, A3.
47.
go back to reference Cooperberg, M. R., et al. (2009). Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. Journal of the National Cancer Institute, 101, 878–887.PubMedCrossRef Cooperberg, M. R., et al. (2009). Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. Journal of the National Cancer Institute, 101, 878–887.PubMedCrossRef
48.
go back to reference MacFarlane, P. (2009). American society of nephrology annual meeting abstract SA-FC347. MacFarlane, P. (2009). American society of nephrology annual meeting abstract SA-FC347.
49.
go back to reference Foley, R. N. (2011). Long interdralytic interval and mortality among patients needing hemodialysis. New England Journal of Medicine, 365, 1099–1107.PubMedCrossRef Foley, R. N. (2011). Long interdralytic interval and mortality among patients needing hemodialysis. New England Journal of Medicine, 365, 1099–1107.PubMedCrossRef
50.
go back to reference Najjar, S. S., et al. (2011). Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL, a randomized controlled trial. Journal of the American Medical Association, 305, 1863–1872.PubMedCrossRef Najjar, S. S., et al. (2011). Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL, a randomized controlled trial. Journal of the American Medical Association, 305, 1863–1872.PubMedCrossRef
51.
go back to reference Grady, D. (2011). Caesarean births are at a high in U.S. New York Times, A1, A17. Grady, D. (2011). Caesarean births are at a high in U.S. New York Times, A1, A17.
52.
go back to reference American College of Obstetrics and Gynecology. (2011). Guidelines for caesarean birth. Practice Bulletin 115, August 2010. American College of Obstetrics and Gynecology. (2011). Guidelines for caesarean birth. Practice Bulletin 115, August 2010.
53.
go back to reference Early Breast Cancer Trialists’ Collaborative Group. (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. The Lancet, 378, 771–784. Early Breast Cancer Trialists’ Collaborative Group. (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. The Lancet, 378, 771–784.
54.
go back to reference Goss, P. E., et al. (2011). Exemestane for breast-cancer prevention in postmenopausal women. New England Journal of Medicine, 364, 2381–2390.PubMedCrossRef Goss, P. E., et al. (2011). Exemestane for breast-cancer prevention in postmenopausal women. New England Journal of Medicine, 364, 2381–2390.PubMedCrossRef
55.
go back to reference The Endocrene Society. (2011, December 5). Obesity in America. The Endocrene Society. (2011, December 5). Obesity in America.
56.
go back to reference Centers for Disease Control. (2011). National diabetes fact sheet. Centers for Disease Control. (2011). National diabetes fact sheet.
58.
go back to reference Science Daily. (2010, June 28). BCG vaccination appears promising as treatment for people with existing type 1 diabetes. Science Daily. (2010, June 28). BCG vaccination appears promising as treatment for people with existing type 1 diabetes.
59.
go back to reference Halle, M., et al. (2010). Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. Journal of the American College of Cardiology, 55, 1237–1239.CrossRef Halle, M., et al. (2010). Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. Journal of the American College of Cardiology, 55, 1237–1239.CrossRef
61.
go back to reference National Lunch Screening Trial Research Teams. (2011). Reduced lung cancer mortality with low-dose computed tomography. New England Journal of Medicine, 365, 395–409.CrossRef National Lunch Screening Trial Research Teams. (2011). Reduced lung cancer mortality with low-dose computed tomography. New England Journal of Medicine, 365, 395–409.CrossRef
62.
go back to reference Holick, M. F. (2004). Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition, 79, 362–371.PubMed Holick, M. F. (2004). Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition, 79, 362–371.PubMed
63.
go back to reference Albanese, E., et al. (2009). Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 dementia research group population-based study. American Journal of Clinical Nutrition, 90, 392–400.PubMedCrossRef Albanese, E., et al. (2009). Dietary fish and meat intake and dementia in Latin America, China, and India: A 10/66 dementia research group population-based study. American Journal of Clinical Nutrition, 90, 392–400.PubMedCrossRef
64.
go back to reference Kay, C. D., et al. (2010). Pistachios increase serum antioxidants and lower serum oxidized-LDL in hypercholesterolemic adults. Journal of Nutrition, 140, 1093–1098.PubMedCrossRef Kay, C. D., et al. (2010). Pistachios increase serum antioxidants and lower serum oxidized-LDL in hypercholesterolemic adults. Journal of Nutrition, 140, 1093–1098.PubMedCrossRef
65.
go back to reference Ding, E. (2006). Chocolate and the prevention of cardiovascular disease: A systematic review. Nutrition and Metabolism, 3, 1–12.CrossRef Ding, E. (2006). Chocolate and the prevention of cardiovascular disease: A systematic review. Nutrition and Metabolism, 3, 1–12.CrossRef
66.
go back to reference Sever, P. S. et al. (2011). The Anglo-Scandinavian cardiac outcomes trial: 11-year mortality follow-up of the lipid-lowering arm in the UK. European Heart Journal (E-pub ahead of print). Sever, P. S. et al. (2011). The Anglo-Scandinavian cardiac outcomes trial: 11-year mortality follow-up of the lipid-lowering arm in the UK. European Heart Journal (E-pub ahead of print).
67.
go back to reference Nuckolls, S. J., et al. (2011). The effect of two intensive statin regimens on the progression of coronary disease. New England Journal of Medicine, 365, 2078–2087.CrossRef Nuckolls, S. J., et al. (2011). The effect of two intensive statin regimens on the progression of coronary disease. New England Journal of Medicine, 365, 2078–2087.CrossRef
68.
go back to reference Hubbard, S. B. (2010, February 22). Statins reduce gallstone risk by one-fifth. Newsmax Health. p. 1. Hubbard, S. B. (2010, February 22). Statins reduce gallstone risk by one-fifth. Newsmax Health. p. 1.
69.
go back to reference Bartelli, A. P., et al. (2009). Grapes, resveratrol and heart health. Journal of Cariovascular Pharmacology, 54, 468.CrossRef Bartelli, A. P., et al. (2009). Grapes, resveratrol and heart health. Journal of Cariovascular Pharmacology, 54, 468.CrossRef
71.
go back to reference Rochon, P. A., et al. (2008). Antipsychotic therapy and short-term serious events in older adults with dementia. Archives of Internal Medicine, 168, 1090–1096.PubMedCrossRef Rochon, P. A., et al. (2008). Antipsychotic therapy and short-term serious events in older adults with dementia. Archives of Internal Medicine, 168, 1090–1096.PubMedCrossRef
72.
go back to reference Wallentin, L., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 361, 1045–1057.PubMedCrossRef Wallentin, L., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 361, 1045–1057.PubMedCrossRef
73.
go back to reference Bode, L. G. M., et al. (2010). Preventing surgical-site infections in nasal carriers of staphylococcus aureus. New England Journal of Medicine, 362, 9–17.PubMedCrossRef Bode, L. G. M., et al. (2010). Preventing surgical-site infections in nasal carriers of staphylococcus aureus. New England Journal of Medicine, 362, 9–17.PubMedCrossRef
74.
go back to reference Naik, G. (2011). Mistakes in scientific studies surge. Wall Street Journal, A1, A12. Naik, G. (2011). Mistakes in scientific studies surge. Wall Street Journal, A1, A12.
75.
go back to reference Grady, D. (2011, September 13). An immune system trained to kill cancer. New York Times. pp. D1–D6. Grady, D. (2011, September 13). An immune system trained to kill cancer. New York Times. pp. D1–D6.
76.
go back to reference Lifton, R. P. (2010). Individual genomes on the horizon. New England Journal of Medicine, 362, 1235–1236.PubMedCrossRef Lifton, R. P. (2010). Individual genomes on the horizon. New England Journal of Medicine, 362, 1235–1236.PubMedCrossRef
77.
go back to reference Feero, W. G., et al. (2011). Genomic medicine: An updated primer. New England Journal of Medicine, 362, 2001–2011.CrossRef Feero, W. G., et al. (2011). Genomic medicine: An updated primer. New England Journal of Medicine, 362, 2001–2011.CrossRef
78.
go back to reference Bonadona, V., et al. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. Journal of the American Medical Association, 305, 2304–2310.PubMedCrossRef Bonadona, V., et al. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. Journal of the American Medical Association, 305, 2304–2310.PubMedCrossRef
79.
go back to reference Lux, S. E., et al. (2011). KRAS gene mutation in colorectal cancer. American Journal of Clinical Pathology, 135, 245–252.CrossRef Lux, S. E., et al. (2011). KRAS gene mutation in colorectal cancer. American Journal of Clinical Pathology, 135, 245–252.CrossRef
80.
go back to reference Tantisira, K. G., et al. (2011). Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. New England Journal of Medicine, 365, 1173–1183.PubMedCrossRef Tantisira, K. G., et al. (2011). Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. New England Journal of Medicine, 365, 1173–1183.PubMedCrossRef
81.
go back to reference Drazen, J. M. (2011). A step toward personalized asthma treatment. New England Journal of Medicine, 365, 1245–1246.PubMedCrossRef Drazen, J. M. (2011). A step toward personalized asthma treatment. New England Journal of Medicine, 365, 1245–1246.PubMedCrossRef
82.
go back to reference Helgadottir, A., et al. (2007). A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science, 316, 1491–1493.PubMedCrossRef Helgadottir, A., et al. (2007). A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science, 316, 1491–1493.PubMedCrossRef
83.
go back to reference Clarke, R., et al. (2009). Genetic variants associated with lp(a) lipoprotein level and coronary disease. New England Journal of Medicine, 361, 2518–2528.PubMedCrossRef Clarke, R., et al. (2009). Genetic variants associated with lp(a) lipoprotein level and coronary disease. New England Journal of Medicine, 361, 2518–2528.PubMedCrossRef
84.
go back to reference Chiu, C., et al. (2010). Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: A genome-wide analysis. Journal of the American College of Cardiology, 55, 1127–1135.PubMedCrossRef Chiu, C., et al. (2010). Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: A genome-wide analysis. Journal of the American College of Cardiology, 55, 1127–1135.PubMedCrossRef
85.
go back to reference Piscione, F., et al. (2008). Effects of ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. Journal of the American College of Cardiology, 52, 1381–1388.PubMedCrossRef Piscione, F., et al. (2008). Effects of ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. Journal of the American College of Cardiology, 52, 1381–1388.PubMedCrossRef
86.
go back to reference Pare, G., et al. (2009). Effects of cyp2c196 genome on outcomes of clopidogrel treatment. New England Journal of Medicine, 363, 1704–1714.CrossRef Pare, G., et al. (2009). Effects of cyp2c196 genome on outcomes of clopidogrel treatment. New England Journal of Medicine, 363, 1704–1714.CrossRef
87.
go back to reference Landon, B., & Tack, N. S. (2007). Gene for brugada syndrome. Circulation, 116, 2260–2268.CrossRef Landon, B., & Tack, N. S. (2007). Gene for brugada syndrome. Circulation, 116, 2260–2268.CrossRef
88.
go back to reference McCormack, M., et al. (2011). HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. New England Journal of Medicine, 364, 1134–1143.PubMedCrossRef McCormack, M., et al. (2011). HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. New England Journal of Medicine, 364, 1134–1143.PubMedCrossRef
89.
go back to reference Chen, P., et al. (2011). Carbamazepine-induced toxic effects and hla-b*1502 screening in Taiwan. New England Journal of Medicine, 364, 1126–1133.PubMedCrossRef Chen, P., et al. (2011). Carbamazepine-induced toxic effects and hla-b*1502 screening in Taiwan. New England Journal of Medicine, 364, 1126–1133.PubMedCrossRef
90.
go back to reference Smith, S. R. (2011). A recipe for medical schools to produce primary physicians. New England Journal of Medicine, 364, 496–497.PubMedCrossRef Smith, S. R. (2011). A recipe for medical schools to produce primary physicians. New England Journal of Medicine, 364, 496–497.PubMedCrossRef
91.
go back to reference Government Accounting Office. (2008). Medicare physician payments: report to congressional committees. Highlights of GAO-08-65. Government Accounting Office. (2008). Medicare physician payments: report to congressional committees. Highlights of GAO-08-65.
92.
go back to reference Beckman, H. (2009). Three degrees of separation. Annals of Internal Medicine, 151, 890–891.PubMed Beckman, H. (2009). Three degrees of separation. Annals of Internal Medicine, 151, 890–891.PubMed
93.
go back to reference Livington, E. H. (2011). Primium non nocere. Annals of Internal Medicine, 155, 329–330. Livington, E. H. (2011). Primium non nocere. Annals of Internal Medicine, 155, 329–330.
94.
go back to reference Cassel, C. K., & Ruben, D. B. (2011). Specialization, subspecialization, and subsubspecialization in internal medicine. New England Journal of Medicine, 364, 1169–1173.PubMedCrossRef Cassel, C. K., & Ruben, D. B. (2011). Specialization, subspecialization, and subsubspecialization in internal medicine. New England Journal of Medicine, 364, 1169–1173.PubMedCrossRef
Metadata
Title
Opportunities for Cost Reduction of Medical Care: Part 3
Authors
Monte Malach
William J. Baumol
Publication date
01-08-2012
Publisher
Springer US
Published in
Journal of Community Health / Issue 4/2012
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-011-9534-8

Other articles of this Issue 4/2012

Journal of Community Health 4/2012 Go to the issue